“…Aloin, an anthraquinone glycoside derived from aloe leaves, has shown to inhibit human cervical, breast, and ovarian cancer cells as well as leukemia cells, exerting also antiangiogenic properties (Harlev et al, 2012;Niciforovic et al, 2007;Pan et al, 2013). Aloe emodin might represent a suitable antitumor drug candidate for the treatment of various human cancers, such as colon, gastric, bladder, lung, tongue, nasopharyngeal, uterine, and liver carcinoma, neuroectodermal tumor, leukemia, Ewing's sarcoma, neuroblastoma, and glioma (Acevedo-Duncan et al, 2004;Chen et al, 2007b;Harlev et al, 2012;Ismail et al, 2013;Pecere et al, 2000). However, only limited data are available on the safety of Aloe vera supplements leaving this issue controversial and uncertain.…”